Merck ready to quickly deploy Covid antiviral pill if it gets regulatory approval, CEO says
October 28, 2021 at 09:04 AM EDT
"We're on pace to have 10 million courses ready before the end of this year, and more than double that next year," Merck CEO Robert Davis told CNBC on Thursday.
